Tissue and cellular distribution of gold nanoparticles varies based on aggregation/agglomeration status

Athena M Keene1, David Peters, Rodney Rouse

  • 1US FDA, Center for Drug Evaluation & Research, Office of Testing & Research, Division of Drug Safety Research, Building 64 Room 2086 HFD 910, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Summary

Gold nanoparticle superstructures show different biological impacts than primary particles. Characterizing nanomaterial structures is crucial for safety assessment before in vivo administration.